• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Parexel Launches Expert Office

Parexel Launches Expert Office

November 13, 2009
CenterWatch Staff

Parexel has established The Expert Office, which provides a single point of contact for clients to more quickly access the company’s worldwide clinical research expertise.

The Expert Office aligns the company's leading medical, therapeutic area, regulatory, and clinical operations experts with their counterparts at biopharmaceutical companies. It is designed to deliver a new level of strategic partnering based on program design expertise, operational excellence, and project leadership.

"Biopharmaceutical companies face myriad regulatory, medical, and scientific issues that are changing the clinical development environment, and Parexel is committed to easing these challenges for our customers. The Expert Office has been designed to provide customers with access to a global team of experts who work closely with them to develop customized strategies and oversee the optimal execution of trials. The Expert Office signals a truly new level of strategic partnering between Parexel and our customers,” said Mark A. Goldberg, M.D., chief operating officer, Parexel.

The Expert Office includes top specialists in their fields, many of whom are former regulators, pharmaceutical company executives, and leaders of medical institutes. The team’s expertise spans phase I through phase IV clinical research and a broad range of therapeutic areas, including but not limited to oncology, cardiology, neurology, rheumatology, and infectious disease.

“Customers are increasingly looking to Parexel to provide insightful strategic guidance related to their compounds in development,” said Udo Kiessling, M.D., corporate vice president and chief medical officer, who heads The Expert Office at Parexel. “Our thought leaders form a comprehensive, cohesive team that provides a strong relationship among medical practice, regulatory affairs, and clinical operations across a broad range of therapeutic areas. This consolidation of knowledge throughout the lifecycle of a program is focused on helping biopharmaceutical companies make faster, better informed development and commercialization decisions and accelerate clinical research.”

Upcoming Events

  • 24May

    Powering an Effective Oversight Strategy with Clinical and Operational Insights

  • 25May

    2022 WCG Avoca Quality & Innovation Summit: Own the Future

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing